1. Investors in AbbVie, Lilly, Amgen and More Set to Vote on Executive Pay, drug pricing

    Investors in AbbVie, Lilly, Amgen and More Set to Vote on Executive Pay, drug pricing

    Several drugmakers resisted shareholder resolutions into the relationship between executive pay and drug prices. (Pixabay) Despite resistance from top pharma companies, shareholders are set to vote this spring on resolutions seeking more information about potential links between executive pay and rising drug prices...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
  2. Quotes

    1. Given that information relating to executive compensation programs, plans, and practices is already disclosed as part of the proxy statement, we believe an annual report is unnecessary.
  3. Topics Mentioned